{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:39:41Z","timestamp":1648813181990},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.reuma.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T12:20:28Z","timestamp":1483014028000},"page":"239-240","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["S\u00edndrome de activaci\u00f3n macrof\u00e1gica: experiencia sobre el cuestionado papel del etop\u00f3sido"],"prefix":"10.1016","volume":"13","author":[{"given":"Leslye F.","family":"Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla P.","family":"Aedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Miraval-Ni\u00f1o de Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.10.004_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.reuma.2013.05.013","article-title":"S\u00edndrome de activaci\u00f3n de macr\u00f3fago como manifestaci\u00f3n inicial de lupus eritematoso sist\u00e9mico severo de inicio juvenil. Respuesta favorable a ciclofosfamida","volume":"10","author":"Torres","year":"2014","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2016.10.004_bib0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli","year":"2002","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.reuma.2016.10.004_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.reuma.2016.10.004_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3843","article-title":"Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis","volume":"14","author":"Bode","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2016.10.004_bib0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.reuma.2016.10.004_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","article-title":"Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"13","author":"Boom","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"key":"10.1016\/j.reuma.2016.10.004_bib0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08035320600649713","article-title":"Macrophage activation syndrome in juvenile idiopathic arthritis","volume":"95","author":"Cortis","year":"2006","journal-title":"Acta Paediatr Suppl."},{"key":"10.1016\/j.reuma.2016.10.004_bib0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: Case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2016.10.004_bib0090","first-page":"2120","article-title":"Etanercept in the treatment of macrophage activation syndrome","volume":"28","author":"Prahalad","year":"2001","journal-title":"J Rheumatol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16301346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16301346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:50:21Z","timestamp":1536137421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X16301346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1699258X16301346"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.10.004","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de activaci\u00f3n macrof\u00e1gica: experiencia sobre el cuestionado papel del etop\u00f3sido","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}